Kazia Therapeutics Ltd ADR share price logo

Kazia Therapeutics Ltd ADR Share Price

NASDAQ: KZIA

Small Cap

$10.23

-0.26

(-2.43%)

as on

Kazia Therapeutics Ltd ADR Stock Performance

as on April 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $9.85
    $10.68
    downward going graph

    3.71%

    Downside

    4.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.90
    $17.40
    downward going graph

    71.65%

    Downside

    70.09%

    Upside

    downward going graph

Kazia Therapeutics Ltd ADR share price movements today

Previous Close
$10.49
Open
$10.28
Volume
377.0K
Day's Low - High
$9.85 - $10.68
52 Week Low - High
$2.90 - $17.40

Kazia Therapeutics Ltd ADR Historical Returns

1 Month Return
+ 40.24 %
3 Month Return
+ 48.16 %
1 Year Return
+ 239.48 %
3 Year Return
-85.01 %
5 Year Return
-98.02 %

Kazia Therapeutics Ltd ADR Stock Fundamentals & Key Indicators

Check Kazia Therapeutics Ltd ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$119.9M

EPS (TTM)

-0.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

1.0118

EBITDA

-17.8M

Revenue (TTM)

1.9M

Profit Margin

0.00%

Return On Equity TTM

-106.90%

Kazia Therapeutics Ltd ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kazia Therapeutics Ltd ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Kazia Therapeutics Ltd ADR image
Kazia Therapeutics Ltd ADR
BUY$119.9M-98.02%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.3B126.09%133.478.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.7B99.85%28.6532.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.5BNA128.255.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.2B47.96%18.0531.41%

Stock Returns calculator for Kazia Therapeutics Ltd ADR Stock including INR - Dollar returns

The Kazia Therapeutics Ltd ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Kazia Therapeutics Ltd ADR investment value today

Current value as on today

₹3,63,425

Returns

₹2,63,425

(+263.42%)

Returns from Kazia Therapeutics Ltd ADR Stock

₹2,31,068 (+231.07%)

Dollar Impact

₹32,357 (+32.36%)

Analyst Recommendation on Kazia Therapeutics Ltd ADR Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Kazia Therapeutics Ltd ADR. Average target price of $21.39

Kazia Therapeutics Ltd ADR Share Price Target

Get share price movements and forecasts by analysts on Kazia Therapeutics Ltd ADR.

What analysts predicted

52.17%UPSIDE

Target Price

$21.39

Current Price

$10.23

Analyzed by

7 Analysts

Target

$21.39

Kazia Therapeutics Ltd ADR target price $21.39, a slight upside of 52.17% compared to current price of $10.23. According to 7 analysts rating.

Kazia Therapeutics Ltd ADR Stock’s Investor Sentiment and Interest

Search interest for Kazia Therapeutics Ltd ADR Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:39% versus previous 30 day period

Kazia Therapeutics Ltd ADR Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Mar 2023
Sep 2023
Dec 2023
Sep 2024
Dec 2024
Sep 2025
Total Revenue
-1
0
0
0
2
0
0
Gross Profit
-1
0
0
0
2
0
0
Operating Income
-25
-5
-10
-8
-19
-9
-4
EBITDA
-11
-4
-9
-7
-18
-8
-4
Interest Expense
4
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
Income Before Tax
-11
-3
-7
-8
-18
-10
-11
Income Tax Expense
0
0
0
0
0
0
-1
Net Income
-7
-2
-4
-5
-17
-10
-9
Net Profit Margin
407.56%
-1237257.55%
-687897.30%
-176470260.00%
-723.68%
-46899.11%
-50487.24%

Kazia Therapeutics Ltd ADR Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
3
6
0
0
0
11
0
0
1
0
Gross Profit
3
6
0
0
0
11
0
0
1
0
Operating Income
-12
-10
-12
-8
-12
-6
-25
-24
-28
-14
EBITDA
-11
-9
-10
-7
-11
-5
-23
-22
-26
-13
Interest Expense
-
0
-
2
0
5
0
-
-
-
Depreciation
-
1
1
1
1
1
1
1
1
0
Income Before Tax
-12
-10
-6
-10
-12
-8
-25
-20
-27
-22
Income Tax Expense
2
0
0
0
0
0
0
0
0
-1
Net Income
-8
-8
-4
-7
-8
-6
-17
-13
-17
-20
Net Profit Margin
-296.29%
-121.42%
-46071.10%
-656230.03%
-1261.75%
-55.46%
-250140.00%
-3687419.82%
-1160.23%
-49290.48%

Kazia Therapeutics Ltd ADR Quarterly Cash Flow

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Sep 2024
Dec 2024
Sep 2025
Dec 2025
Net Income
-13
-3
-3
-6
-8
-17
-5
-9
-12
Operating Cash Flow
-8
-3
-3
-6
-6
-3
-4
-4
-9
Investing Cash Flow
7
-
-
-5
5
-
-
-
-
Financing Cash Flow
5
3
3
7
4
0
4
5
73
Change in Cash
4
0
0
-3
3
-3
-
1
65

Kazia Therapeutics Ltd ADR Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-10
-6
-10
-12
-8
-25
-20
-26
-20
Operating Cash Flow
-11
-8
-6
-8
-9
-22
-15
-9
-13
Investing Cash Flow
-7
0
2
-2
-2
-2
-
-
-
Financing Cash Flow
0
3
3
12
28
3
12
5
15
Change in Cash
-18
-8
0
3
18
-20
-2
-3
2

Global Institutional Holdings in Kazia Therapeutics Ltd ADR

Funds
Holdings
Alyeska Investment Group, L.P.
6.46%
Advisor Group Holdings, Inc.
0%
Bleichroeder LP
3.5%
Velan Capital Investment Management LP
2.63%
SRS Capital Advisors Inc
0%
See all

Insights on Kazia Therapeutics Ltd ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, KZIA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, KZIA stock has moved up by 40.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 48.6% return, outperforming this stock by 133.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -9.95M → -12.32M (in $), with an average decrease of 23.8% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 2.48M → 19.71K (in $), with an average decrease of 55.3% per quarter

About Kazia Therapeutics Ltd ADR

Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma; in Phase II trial to treat isocitrate dehydrogenase-mutant glioma, primary central nervous system (CNS) lymphoma, diffuse intrinsic pontine glioma, and brain metastases; and in pre-clinical studies to treat triple-negative breast cancer, as well as for the treatment of atypical rhabdoid/teratoid tumors. It also develops EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3 that is in Phase I clinical trial to treat advanced solid tumors and ovarian cancer. The company has collaborations with the Australian and New Zealand Children's Haematology/Oncology Group, Genentech Inc., Global Coalition for Adaptive Research, Vivesto AB, Simcere Pharmaceutical Group Ltd, Evotec SE, Sovargen Co., Ltd, and QIMR Berghofer Medical Research Institute. Kazia Therapeutics Limited was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
OrganisationKazia Therapeutics Ltd ADR
HeadquartersThree International Towers, Sydney, NSW, Australia, 2000
IndustryBiotechnology
CEODr. John Edwin Friend II, M.D.
E-voting on sharesClick here to vote

Key Management of Kazia Therapeutics Ltd ADR

Name

Title

Dr. John Edwin Friend II, M.D.

Chief Executive Officer

Mr. Jeffrey Bonacorda

VP of Finance & Controller

Ms. Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAI, GAIC

Company Secretary

Dr. Sudha Rao

Chief Scientific Officer

FAQs

What is Kazia Therapeutics Ltd ADR share price today?

Kazia Therapeutics Ltd ADR share price today is $10.23 as on at the close of the market. Kazia Therapeutics Ltd ADR share today touched a day high of $10.68 and a low of $9.85.

What is the 52 week high and 52 week low for Kazia Therapeutics Ltd ADR share?

Kazia Therapeutics Ltd ADR share touched a 52 week high of $17.4 on and a 52 week low of $2.9 on . Kazia Therapeutics Ltd ADR stock price today i.e. is closed at $10.23,which is 41.21% down from its 52 week high and 252.76% up from its 52 week low.

What is Kazia Therapeutics Ltd ADR's market capitalisation today?

Kazia Therapeutics Ltd ADR market capitalisation is $0.00T as on .

How to invest in Kazia Therapeutics Ltd ADR Stock (KZIA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kazia Therapeutics Ltd ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kazia Therapeutics Ltd ADR Shares that will get you 0.1466 shares as per Kazia Therapeutics Ltd ADR share price of $10.23 per share as on April 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Kazia Therapeutics Ltd ADR Stock (KZIA) from India?

Indian investors can start investing in Kazia Therapeutics Ltd ADR (KZIA) shares with as little as ₹93.505 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹935.05 in Kazia Therapeutics Ltd ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Kazia Therapeutics Ltd ADR share’s latest price of $10.23 as on April 22, 2026 at 1:29 am IST, you will get 0.9775 shares of Kazia Therapeutics Ltd ADR. Learn more about fractional shares .

What are the returns that Kazia Therapeutics Ltd ADR has given to Indian investors in the last 5 years?

Kazia Therapeutics Ltd ADR stock has given -98.02% share price returns and 23.44% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?